Field Intelligence Counterfeit Gear · Hemorrhage Control
Fake Israeli Bandages, Counterfeit Hemostatic Gauze, and the Influencers Cashing In
A $6 look-alike tourniquet delivered 14 newtons of force in a controlled bench test. The real device delivered 65. That gap is not a discount. It is the difference between a clot and a casualty.
Somebody with a beard, a truck, and 340,000 followers is selling you a bandage right now. He is not a clinician. He has never packed a groin wound at three in the morning while somebody's brother screamed at him to hurry up. He found a supplier on Alibaba, ordered a pallet of tan-colored packaging with Hebrew-looking font on it, and marked it up 400% from twenty-two cents a unit. The comments are full of people thanking him for making lifesaving gear affordable.
They are not thanking him for lifesaving gear. They are thanking him for the shape of lifesaving gear.
This is not a brand-loyalty argument and I have no interest in defending anybody's margin, including mine. It is a materials-science and regulatory argument, and the data behind it is public, peer-reviewed, and grim. Here is what is actually known.
What the bench data says about cheap look-alikes
In 2023 a team led by Emanuele Lagazzi published the cleanest head-to-head test of this problem we have. They bought 50 uncertified "look-alike" tourniquets off Amazon and AliExpress and compared them against 25 genuine Combat Application Tourniquets. Certified Stop the Bleed instructors applied every single device to a medical-grade manikin leg instrumented with eight force sensors, three windlass turns each, under laboratory conditions — meaning the knockoffs got the most favorable possible test. Trained hands. No blood. No noise. No panic.
The look-alikes still failed.
| Measured parameter | Genuine CAT (n=25) | Look-alike (n=50) |
|---|---|---|
| Mean price per device | $27.19 | $6.07 |
| Force applied at application | 65 N | 14 N |
| Force at one hour | 67 N | 14 N |
| Mechanical rupture during placement | 0% | 4% |
| Mean strap length | 94.5 cm | 90.1 cm |
Read the force row again. The knockoff delivered roughly a fifth of the compressive force of the real device, and the difference held at P<.001. A tourniquet has exactly one job: generate circumferential pressure that exceeds arterial pressure. Fall short of that and you have not built a tourniquet. You have built a venous constricting band, which occludes outflow while arterial inflow keeps filling the limb. The published consequence of that specific failure mode is increased blood loss, limb edema, and compartment syndrome. The patient bleeds faster with the device on than without it.
Two of the fifty snapped during placement. Not during a fight. During placement, by an instructor, on a mannequin.
Evidence grade — read this before you quote the numbers
Lagazzi 2023 is a bench study on an instrumented manikin, not perfused tissue and not a human trial. The authors say so themselves and call for perfused-model replication. It sits in the manikin/bench tier of evidence. What makes it usable is the direction and magnitude of the effect: a 4.6-fold force deficit under ideal conditions is not the kind of gap a better testing model reverses.
Then it killed somebody, and we have the paper
April 2022, eastern Ukraine. A 19-year-old soldier steps on an antipersonnel mine and loses both legs below the knee. Responders apply bilateral CAT-style tourniquets and load him for evacuation to an urban trauma center. Somewhere in transit the windlass on the right-side device breaks. Brisk hemorrhage restarts. The casualty-to-provider ratio in the back of that vehicle was bad enough that nobody caught it for an unknown period of time. He died of hemorrhagic shock before arrival.
That is a 2024 case report in the peer-reviewed literature, and it is the whole argument in one paragraph. A CAT-like device. A broken windlass. A preventable death.
The counterfeit did not fail because the responders were untrained. It failed because it was a counterfeit.
"Israeli bandage" is a nickname, not a standard
Here is where the confusion gets monetized. The Emergency Bandage was invented by an Israeli combat medic named Bernard Bar-Natan, produced by First Care Products, later sold to PerSys Medical in Houston, and now manufactured under Safeguard Medical in the same Israeli factory. Roughly 1.5 to 2 million units a year. It carries FDA clearance as a non-pneumatic tourniquet.
"Israeli bandage," on the other hand, is a colloquialism. No agency owns it. No standards body defines it. Anybody can print those two words on a pouch and sell it legally as long as they do not counterfeit somebody's trademark — and plenty do that too.
The engineering that makes the real device work is concentrated in one component most buyers never inspect: the pressure applicator bar. Once the pad is on the wound, the elastic leader wraps around that rigid bar and reverses direction, which converts a distributed circumferential wrap into focused compression directly over the bleeding source. That is a mechanical advantage, and it only exists if the bar is genuinely rigid and genuinely anchored.
On the cheap versions, that bar is the first thing engineered down to a price. It flexes. It pulls out of its seating. The elastic loses its recoil after one wrap. The closure bar does not hold. The pad is not sterile because nobody validated a sterilization cycle. You end up holding a $4 ace wrap with a plastic stick in it, and you find that out with your hands inside somebody.
Fake hemostatic gauze is the most dangerous fake in the bag
A knockoff tourniquet at least looks like it is doing something. Fake hemostatic gauze looks identical to real hemostatic gauze in every way that a buyer can see, and the difference is invisible until the moment it matters.
Real hemostatic dressings work through a named, characterized chemical mechanism. Kaolin — the agent in QuikClot Combat Gauze — is a negatively charged mineral that binds Factor XII and triggers contact activation of the intrinsic coagulation pathway. It generates no heat. Chitosan, the agent in Celox Gauze and ChitoGauze, works differently: it drives cellular aggregation and adheres aggressively to wet tissue, largely independent of the clotting cascade.
A gauze with no active agent in it is gauze. It will not accelerate anything. And because the packaging says "hemostatic," the person using it will pack it, hold pressure for three minutes, see continued bleeding, and reasonably conclude the wound is unsurvivable — instead of concluding that the product was a lie.
What is actually on the list
The TCCC Guidelines dated 25 January 2024 name QuikClot Combat Gauze as the CoTCCC hemostatic dressing of choice for compressible external hemorrhage not amenable to a limb tourniquet. The listed alternative hemostatic adjuncts are Celox Gauze, ChitoGauze, XStat for deep narrow-tract junctional wounds, and the iTClamp. The guideline also directs at least three minutes of sustained direct pressure, and instructs that if one dressing fails, you remove it and repack with a fresh dressing of the same or a different type.
That list is short on purpose. Nothing sold from an Instagram story link is on it. And note the framing: TCCC is governed by the CoTCCC. TECC is a separate framework under C-TECC and does not automatically mirror CoTCCC decisions — do not assume a TCCC listing carries across.
Correct doctrine, since the fakes get this wrong too
Use an effective hemostatic gauze — kaolin or chitosan — with meticulous wound packing and sustained pressure. Anticoagulation increases the risk of failure and recurrent hemorrhage; reassess frequently and escalate mechanical hemorrhage control and systemic anticoagulant reversal when available.
There is no drug-history-based selection rule in the TCCC Guidelines. Anyone telling you "if the patient is on blood thinners, switch to chitosan" is inventing a protocol that does not exist in the guideline. Never delay hemorrhage control to work out which anticoagulant somebody takes. Wound exposure, packing directly onto the bleeding source, enough material, and sustained compression matter more than the choice between two approved agents.
The WoundStat lesson nobody selling gear on social media has heard
In April 2008 the CoTCCC added WoundStat, a smectite granule, as a backup hemostatic agent. It worked. It stopped bleeding effectively in the efficacy models.
Then investigators noticed granules inside injured vessels. Bijan Kheirabadi's follow-up swine vascular injury study found endothelial toxicity, large intraluminal thrombi in most treated vessels, and emboli in the lungs of two animals. On 3 February 2009 the Committee reviewed the histology and pulled WoundStat out of the guidelines entirely, leaving Combat Gauze as the agent of choice.
Sit with that. A product that stopped bleeding was removed from the standard because a downstream safety signal showed it damaged vessel walls and threw clot to the lungs. That process — efficacy first, then a safety model, then a committee willing to reverse itself — is the entire value of regulated medical devices. An unregistered gauze shipped in a poly mailer from a warehouse nobody has inspected never enters that process at any point. There is no safety study. There is no adverse-event pathway. There is nobody to recall it.
The regulatory piece, in plain English
Hemostatic dressings are FDA-regulated medical devices. They sit under classification names like "Hemostatic Wound Dressing Without Thrombin Or Other Biologics" (product code QSY), and non-absorbable hemostatic gauze for temporary internal use falls under 21 CFR 878.4454 as a Class II device with its own product code. Class II means a manufacturer must file a 510(k) premarket notification and demonstrate substantial equivalence to a legally marketed predicate before selling it in the United States. They must register their establishment. They must list the device. They are subject to good manufacturing practice requirements and to prohibitions against misbranding and adulteration.
Every one of those records is public and free. You can search the FDA 510(k) database yourself in about ninety seconds. If a product marketed as a hemostatic dressing has no clearance number, no registered manufacturer, and no listing, one of two things is true: it is being sold illegally, or it is not actually a hemostatic dressing.
Why influencers keep doing this
Because the economics are absurd and, until somebody dies, the consequences are theoretical.
The margin on a $6 sourced unit sold at $29 with "COMBAT MEDIC APPROVED" slapped on the graphic is better than the margin on almost anything else a content account can move. There is no inventory expertise required. No regulatory affairs person. No liability insurance anybody bothered to price. The audience already trusts the face, and trust in a face transfers to trust in a product far more efficiently than any ad ever will.
That transfer is exactly what the Federal Trade Commission regulates. The FTC's Endorsement Guides at 16 CFR Part 255, revised in 2023, are explicit: objective product claims require substantiation, and the advertiser is responsible for that substantiation. Endorsers must clearly and conspicuously disclose material connections. Intermediaries can be held liable for disseminating representations they knew or should have known were deceptive. In November 2023 the FTC sent warning letters to a dozen online health influencers over inadequate disclosures alone.
Selling a device that treats life-threatening hemorrhage is not lifestyle content with a discount code attached. It is the marketing of a medical device, and "I'm just a guy who likes gear" is not a regulatory category.
Charisma is not a quality-control system. Follower count is not a 510(k).
Audit your kit tonight — ten minutes, no tools
Pull everything out. Lay it on a table. Work the list in order.
- Price-check backward. A genuine CAT Gen 7 from an authorized dealer lands in a consistent band well north of the counterfeit market. If a tourniquet cost you under fifteen dollars, or arrived in a three-pack for the price of one, treat it as fake until proven otherwise. There is no legitimate supply chain that produces an $8 tourniquet.
- Inspect the windlass. Rigid, dense, deeply ribbed. If it has any flex under hand pressure or feels like hollow injection-molded plastic, it will break under load.
- Check the buckle-to-strap junction. The manufacturer's published authentication feature for the CAT Gen 7 is a sonic weld, not stitching. Most fakes are sewn. Look for raised lettering on the routing buckle and on both ends of the windlass rod.
- Find the lot number and manufacture date. On every device. Every real medical device carries traceable lot and date markings, because that is what a recall runs on. Blurry printing, missing lot codes, or no date at all means no traceability and no recall pathway.
- Read the gauze label for a named agent. It must say kaolin or chitosan, or name the product by its cleared trade name. The word "hemostatic" by itself, with no named active agent, is decoration.
- Verify the packaging seal. Hemostatic gauze ships vacuum-sealed in a foil pouch with defined tear points. Combat Gauze also carries an X-ray detectable strip. A loose poly bag is not a sterile barrier.
- Look up the manufacturer. Real name, real address, real 510(k) number on the label or the box. Then search it in the FDA 510(k) database. Ninety seconds. If nothing comes back, you have your answer.
- Check the expiration on your pressure dressing. The genuine Emergency Bandage carries a multi-year dated shelf life from a validated sterilization process. If the pouch has no expiration date printed on it, nobody validated anything.
- Flex the pressure bar. On a real Emergency Bandage the applicator bar is rigid and seated. If it bends between your fingers or shifts in its housing, it will not focus pressure over the wound and the whole mechanism is gone.
- Ask where it came from. Manufacturer or authorized distributor, or a third-party marketplace seller you cannot name. If it is the second one, you do not know what you own.
You already bought the fake. Now what.
Do not demote it to "backup." That is the single most common mistake, and it is how a counterfeit ends up being the device somebody grabs at the worst possible moment, because it was in the bag and the bag was closest.
Cut the strap. Then it is a training aid, and honestly it is a useful one — hand it to a student next to the real thing and let them feel the difference in the windlass. Failing that, throw it away. A tourniquet you do not trust has negative value in a kit, because it consumes the seconds you needed for the one that works.
Then request a refund and report the listing. Marketplace platforms remove listings when volume of reports crosses a threshold, and the FDA takes device complaints through MedWatch. Neither is fast. Both are better than silence.
Buy on evidence, not on vibes
Start with the doctrine, then buy to it. We publish the reasoning behind every product we carry, including the studies that argue against things we sell.
→ Best Tourniquets 2026: Evidence-Based Comparison
→ Hemostatic Agent Comparison: Combat Gauze vs. Celox vs. ChitoGauze
→ Massive Hemorrhage Control — authenticated supply chain
→ The Trauma Brief — free field reference, no upsell
The part that actually matters
The people buying this stuff are not stupid. They are doing something genuinely responsible — deciding to carry the capability to stop a hemorrhage — and they are being punished for it by a market that rewards volume over verification.
They are also, almost always, buying it for somebody else. A wife's car. A kid's dorm room. A range bag that a friend will be reaching into. That is who eats the cost of a windlass that snaps at 14 newtons: not the buyer, and never the seller.
Buy the real thing, from someone who can tell you the lot number, the clearance, and the study behind it. Then go train with it until you can run it in the dark, one-handed, with the wrong hand. The gear was always the cheap part.

Straight answers
How can I tell if my Israeli bandage is fake?
Check four things in this order: a printed lot number and expiration date on the pouch, a named manufacturer with a real address, a rigid pressure applicator bar that does not flex or shift in its housing, and an intact sealed sterile barrier. The genuine Emergency Bandage is produced under Safeguard Medical (formerly PerSys Medical, originally First Care Products) and is FDA-cleared as a non-pneumatic tourniquet. If the pouch carries no date, no lot, and no manufacturer, you are holding an unregulated elastic wrap.
Is cheap hemostatic gauze from Amazon actually dangerous, or just less effective?
Both, and the danger is the bigger problem. A dressing with no active hemostatic agent will not accelerate clotting at all, which wastes the three minutes of sustained pressure the TCCC Guidelines require and delays escalation. Separately, unregulated agents carry unknown safety profiles. The WoundStat case is the precedent: an effective agent was pulled from the TCCC Guidelines in 2009 after swine safety studies showed endothelial toxicity, intraluminal thrombi, and pulmonary emboli. Unregistered products never undergo that scrutiny at all.
Which hemostatic dressings are actually CoTCCC-recommended?
Per the TCCC Guidelines dated 25 January 2024: QuikClot Combat Gauze is the CoTCCC hemostatic dressing of choice. Listed alternative hemostatic adjuncts are Celox Gauze, ChitoGauze, XStat (best for deep, narrow-tract junctional wounds), and the iTClamp. Apply with at least three minutes of direct pressure. If one dressing fails, remove it and repack with a fresh dressing of the same or a different type. TECC is governed separately by C-TECC and does not automatically mirror CoTCCC decisions.
Does a patient on blood thinners need chitosan gauze instead of kaolin?
No. There is no drug-history-based selection rule in the TCCC Guidelines, and the evidence does not support kaolin being ineffective in anticoagulated blood. Use an effective hemostatic gauze — kaolin or chitosan — with meticulous wound packing and sustained pressure. Anticoagulation raises the risk of failure and recurrent hemorrhage, so reassess frequently and escalate mechanical hemorrhage control and systemic anticoagulant reversal when available. Never delay hemorrhage control to determine what medication someone takes.
How do I verify a hemostatic dressing is FDA-cleared?
Search the manufacturer or device name in the FDA's public 510(k) premarket notification database at accessdata.fda.gov. Hemostatic dressings are regulated devices — non-absorbable hemostatic gauze for temporary internal use falls under 21 CFR 878.4454 as Class II, and topical hemostatic wound dressings without thrombin carry product code QSY. A legitimate manufacturer will have a clearance record, a registered establishment, and a device listing. It takes under two minutes and costs nothing.
Are all budget tourniquets counterfeit, or are some just generic?
Not all are counterfeit in the trademark sense, but the distinction rarely helps the buyer. The 2023 Lagazzi bench study tested uncertified look-alikes — devices lacking both FDA clearance and CE marking — not trademark counterfeits specifically, and they still delivered 14 N of force against 65 N for the genuine CAT and ruptured at 4% during placement. Whether a device is a counterfeit or merely uncertified, what matters is whether it has been through a regulatory process and appears on the CoTCCC recommended list.
References
- Lagazzi E, Ballardini G, Drogo A, et al. The certification matters: a comparative performance analysis of Combat Application Tourniquets versus non-certified CAT look-alike tourniquets. Prehosp Disaster Med. 2023;38(4):450–455. doi:10.1017/S1049023X23006076
- Limb hemorrhage control failure with counterfeit tourniquet: a Ukrainian war MEDEVAC case report. PubMed PMID 39276363 (2024).
- Committee on Tactical Combat Casualty Care. Tactical Combat Casualty Care Guidelines, 25 January 2024. Massive Hemorrhage section.
- Kheirabadi BS, Mace JE, Terrazas IB, et al. Safety evaluation of new hemostatic agents, smectite granules, and kaolin-coated gauze in a vascular injury wound model in swine. J Trauma. 2010;68(2):269–278.
- Bennett BL, Littlejohn LF, Kheirabadi BS, et al. Management of external hemorrhage in Tactical Combat Casualty Care: chitosan-based hemostatic gauze dressings — TCCC Guidelines Change 13-05. J Spec Oper Med. 2014;14(3):40–57.
- US Food and Drug Administration. 510(k) Premarket Notification Database; device classification "Hemostatic Wound Dressing Without Thrombin Or Other Biologics," product code QSY; 21 CFR 878.4454, Class II.
- Federal Trade Commission. Guides Concerning Use of Endorsements and Testimonials in Advertising, 16 CFR Part 255 (revised 2023).
- Basadonna G. QuikClot Combat Gauze for hemorrhage control [letter]. Prehosp Disaster Med. 2012. Kaolin/Factor XII contact activation mechanism.
Clinician-founded. Veteran-led. SDVOSB-certified.
South Florida, US of A · tactical-medicine.com
Clinical and content correspondence: doc@tactical-medicine.com
Leave a comment